Breast Cancer Core Needle Biopsy Market Growth, Size, Trends Analysis - By Technology, By End-use- Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Breast Cancer Core Needle Biopsy Market Introduction and Overview

According to SPER market research, 'Global Breast Cancer Core Needle Biopsy Market Size- By Technology, By End-use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Breast Cancer Core Needle Biopsy Market is predicted to reach 1398.03 million by 2034 with a CAGR of 4.86%.

Breast cancer core needle biopsy is a minimally invasive diagnostic method that takes small samples of breast tissue for examination. To recover tissue cores, a hollow needle is placed into the suspicious area, guided by imaging modalities such as ultrasonography, mammography, or MRI. This approach accurately detects malignant cells while providing minimal discomfort and avoiding the need for surgical biopsy.

Restraints: The breast cancer core needle biopsy market faces various challenges that could hamper its growth. One key impediment is the growing demand for less invasive diagnostic methods like as liquid biopsies and micro needle aspiration, which can be more cost-effective. Furthermore, stringent regulatory requirements for product licensing and clinical validation can cause delays in the introduction of new technologies, increasing development costs and limiting market entry for smaller businesses.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Technology, By End-use

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered Argon Medical Devices, Becton - Dickinson and Company, C.R. Bard, Inc., Cook Medical Incorporated, Encapsule Medical Devices LLC, Ethicon Surgical Technologies, Gallini SRL, Hologic, Inc., Intact Medical Corporation, Leica Biosystems Nussloch GmbH.

By Technology: Based on the Technology, Global Breast Cancer Core Needle Biopsy Market is segmented as; MRI-based Breast Biopsy, Ultrasound-based Breast Biopsy, Mammography-based Breast Biopsy, CT-based Breast Biopsy, Other Image Based Breast Biopsy.

By End-use: Based on the End-use: Global Breast Cancer Core Needle Biopsy Market is segmented as; Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Product Code: HLCA25244

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Breast Cancer Core Needle Biopsy Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Breast Cancer Core Needle Biopsy Market

7. Global Breast Cancer Core Needle Biopsy Market, By Technology (USD Million) 2021-2034

7.1. MRI-based Breast Biopsy
7.2. Ultrasound-based Breast Biopsy
7.3. Mammography-based (Stereotactic) Breast Biopsy
7.4. CT-based Breast Biopsy
7.5. Other Image Based Breast Biopsy

8. Global Breast Cancer Core Needle Biopsy Market, By End-Use (USD Million) 2021-2034

8.1. Hospitals & Diagnostic Laboratories
8.2. Pharmaceutical & Biotechnology Companies
8.3. Academic & Research Institutes

9. Global Breast Cancer Core Needle Biopsy Market, (USD Million) 2021-2034

9.1. Global Breast Cancer Core Needle Biopsy Market Size and Market Share

10. Global Breast Cancer Core Needle Biopsy Market, By Region, (USD Million) 2021-2034

10.1. Asia-Pacific
- 10.1.1. Australia
- 10.1.2. China
- 10.1.3. India
- 10.1.4. Japan
- 10.1.5. South Korea
- 10.1.6. Rest of Asia-Pacific
10.2. Europe
- 10.2.1. France
- 10.2.2. Germany
- 10.2.3. Italy
- 10.2.4. Spain
- 10.2.5. United Kingdom
- 10.2.6. Rest of Europe
10.3. Middle East and Africa
- 10.3.1. Kingdom of Saudi Arabia
- 10.3.2. United Arab Emirates
- 10.3.3. Qatar
- 10.3.4. South Africa
- 10.3.5. Egypt
- 10.3.6. Morocco
- 10.3.7. Nigeria
- 10.3.8. Rest of Middle-East and Africa
10.4. North America
- 10.4.1. Canada
- 10.4.2. Mexico
- 10.4.3. United States
10.5. Latin America
- 10.5.1. Argentina
- 10.5.2. Brazil
- 10.5.3. Rest of Latin America

11. Company Profile

11.1. Argon Medical Devices
- 11.1.1. Company details
- 11.1.2. Financial outlook
- 11.1.3. Product summary
- 11.1.4. Recent developments
11.2. Becton- Dickinson and Company
- 11.2.1. Company details
- 11.2.2. Financial outlook
- 11.2.3. Product summary
- 11.2.4. Recent developments
11.3. C.R. Bard, Inc.
- 11.3.1. Company details
- 11.3.2. Financial outlook
- 11.3.3. Product summary
- 11.3.4. Recent developments
11.4. Cook Medical Incorporated
- 11.4.1. Company details
- 11.4.2. Financial outlook
- 11.4.3. Product summary
- 11.4.4. Recent developments
11.5. Encapsule Medical Devices LLC
- 11.5.1. Company details
- 11.5.2. Financial outlook
- 11.5.3. Product summary
- 11.5.4. Recent developments
11.6. Ethicon Surgical Technologies
- 11.6.1. Company details
- 11.6.2. Financial outlook
- 11.6.3. Product summary
- 11.6.4. Recent developments
11.7. Gallini SRL
- 11.7.1. Company details
- 11.7.2. Financial outlook
- 11.7.3. Product summary
- 11.7.4. Recent developments
11.8. Hologic, Inc.
- 11.8.1. Company details
- 11.8.2. Financial outlook
- 11.8.3. Product summary
- 11.8.4. Recent developments
11.9. Intact Medical Corporation
- 11.9.1. Company details
- 11.9.2. Financial outlook
- 11.9.3. Product summary
- 11.9.4. Recent developments
11.10. Leica Biosystems Nuss Loch GmbH
- 11.10.1. Company details
- 11.10.2. Financial outlook
- 11.10.3. Product summary
- 11.10.4. Recent developments
11.11. Others